Alison Cave
Alison is a pharmacologist with a PhD in biochemistry. Her long career includes significant academic and regulatory experience, the latter initially at the Medicines Control Agency and then in senior roles within the Vigilance and Risk Management of Medicine Group at the MHRA and the European Medicines Agency. In addition she was head of cellular, Developmental and Physiological Sciences at the Wellcome Trust and most recently an industrial strategy challenge fund director at UK Research and Innovation.
- Comment
Reducing the impact and £2bn cost of adverse drug reactions
Alison Cave writes how new technology continues to drive the Yellow Card scheme forward, serving to improve user experience and streamline reporting, in order to enhance patient safety